SCHEMBL25055331

SCHEMBL25055331

Cc1cccc(Cn2cc(-c3ccc(O)cc3)nn2)c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CD74 P04233 3/20 0.73
MIF P14174 3/20 0.73
ROCK2 O75116 1/20 0.63
GSK3B P49841 1/20 0.63
AURKB Q96GD4 1/20 0.63
HSP90AA1 P07900 1/20 0.59
HSP90AB1 P08238 1/20 0.59
TEK Q02763 5/20 0.58
KDR P35968 5/20 0.58
EPHB4 P54760 2/20 0.58
HPGD P15428 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
CYP19A1 P11511 1/20 0.56
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29275463 0.89 CYP19A1 (0.72) CD74MIFROCK2GSK3BAURKB
SCHEMBL30185437 0.89 CYP19A1 (0.72) CD74MIFROCK2GSK3BAURKB
SCHEMBL27983562 0.88 ESRRG (0.63) CD74MIFROCK2GSK3BAURKB
SCHEMBL12419414 0.87 ROCK2 (0.58) CD74MIFROCK2GSK3BAURKB
SCHEMBL25055361 0.84 CD74 (1.00) CD74MIFHSP90AA1HSP90AB1NPC1
SCHEMBL29352717 0.81 CYP19A1 (0.72) ROCK2GSK3BAURKBTEKKDR
SCHEMBL16050564 0.81 CYP19A1 (0.72) ROCK2GSK3BAURKBTEKKDR
SCHEMBL12535881 0.79 NPC1 (0.88) GSK3BTEKKDREPHB4NPC1
SCHEMBL3666031 0.78 ROCK2 (1.00) ROCK2GSK3BAURKBTEKKDR
SCHEMBL28331496 0.77 NPC1 (0.76) GSK3BTEKKDREPHB4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584717-B2 MIF modulators YALE UNIVERSITY (US) 2023-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584717-B2 MIF modulators MIF, HMGB2, HMGB3 CD74 15/4885MIF 1/4885ROCK2 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.